Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric conversion from Prograf to Advagraf pharmacokinetic study
2010-020925-42Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tacrolimus in solid organ transplant rejection (SOTR) and Intestinal Transplantation Rejection, sponsored by Astellas Pharma. Primary endpoint: Steady-state tacrolimus systemic exposure. Started Nov 2010; status: completed.
02
Drugs
tacrolimus
03
Conditions
solid organ transplant rejection (SOTR)Intestinal Transplantation Rejection
Beyond the preview
Go deeper on 2010-020925-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020925-42.